Is quinolinic acid involved in the pathogenesis of hepatic encephalopathy?
Bergqvist
P B
PB
Department of Clinical Pharmacology, Lund University Hospital, Sweden.
Heyes
M P
MP
Bengtsson
F
F
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism; D004195:Disease Models, Animal; D005110:Extracellular Space / Q000378:metabolism; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D011167:Portacaval Shunt, Surgical; D017378:Quinolinic Acid / Q000378:metabolism*; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism; D012016:Reference Values; D013997:Time Factors; D014364:Tryptophan / Q000494:pharmacology
D016194:Receptors, N-Methyl-D-Aspartate; D014364:Tryptophan; D017378:Quinolinic Acid